Phenylbutazone toxicosis in the horse: a clinical study.
In a retrospective study of 269 horses that had been treated with phenylbutazone, horses receiving less than or equal to 8.8 mg/kg of body weight/day for less than or equal to 4 days or 2 to 4 mg/kg of body weight/day for up to 50 days remained clinically normal. Anorexia, depression, colic, hypoproteinemia, diarrhea, melena, weight loss, ventral edema, petechial hemorrhages of mucous membranes, oral and gastrointestinal tract erosions and ulcers, renal papillary necrosis, and death were among the complications seen in horses that had received greater than 8.8 mg/kg of body weight/day. In 2 cases, signs suggestive of gastrointestinal-related shock were also evident.
D000284:Administration, Oral; D000818:Animals; D001835:Body Weight; D003106:Colon / Q000473:pathology; D005260:Female; D006734:Horse Diseases / Q000139:chemically induced*; D006736:Horses; D007019:Hypoproteinemia / Q000139:chemically induced / Q000662:veterinary; D007275:Injections, Intravenous; D007592:Joint Diseases / Q000188:drug therapy / Q000662:veterinary; D007794:Lameness, Animal / Q000188:drug therapy; D008297:Male; D010653:Phenylbutazone / Q000008:administration & dosage / Q000633:toxicity*; D011247:Pregnancy; D012189:Retrospective Studies; D012769:Shock / Q000139:chemically induced / Q000662:veterinary; D013997:Time Factors
D010653:Phenylbutazone